Bio A worked for me as well but its not the money spinner yet. Ropren the catalyst. Bio A needs more trials to get it to the pharmaceutical level. But may take a short cut through Russia again?
Who would have thought the worst trading day in the west since September 11 terror stuff? makes launching product in Russia not that silly after all doesn't it? :)>